Abstracto

Orphan drugs and rare diseases.

Soza Takeda*

"Orphan drugs" are medicinal products intended for diagnosis, prevention or treatment of lifethreatening or debilitating rare diseases. They are "orphans" because the pharmaceutical industry has little interest under normal market conditions in developing and marketing drugs intended for only a small number of patients suffering from very rare conditions.